[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "215 731 9450", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 53, "title": "CEO & Chair", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian G. Atwood", "age": 70, "title": "President & Director", "yearBorn": 1953, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 76, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1947, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 42, "title": "CFO & Director", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 53, "title": "Chief Development Officer & Director", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.1915, "open": 0.174, "dayLow": 0.1126, "dayHigh": 0.18, "regularMarketPreviousClose": 0.1915, "regularMarketOpen": 0.174, "regularMarketDayLow": 0.1126, "regularMarketDayHigh": 0.18, "beta": -0.463, "volume": 36109548, "regularMarketVolume": 36109548, "averageVolume": 66399149, "averageVolume10days": 13803450, "averageDailyVolume10Day": 13803450, "bid": 0.1145, "ask": 0.115, "bidSize": 1000, "askSize": 100, "marketCap": 17285994, "fiftyTwoWeekLow": 0.064, "fiftyTwoWeekHigh": 12.8, "fiftyDayAverage": 0.13174, "twoHundredDayAverage": 0.784525, "currency": "USD", "enterpriseValue": 20564504, "floatShares": 22532928, "sharesOutstanding": 150312992, "sharesShort": 1601706, "sharesShortPriorMonth": 2321176, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0107, "heldPercentInsiders": 0.55417997, "heldPercentInstitutions": 0.05079, "shortRatio": 0.29, "shortPercentOfFloat": 0.0208, "impliedSharesOutstanding": 150312992, "bookValue": -2.273, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -2753744, "trailingEps": -1.19, "52WeekChange": -0.9824176, "SandP52WeekChange": 0.31426477, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CERO", "underlyingSymbol": "CERO", "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1638282600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "c96e7212-658f-3054-8625-d2aafea7c5eb", "messageBoardId": "finmb_1673740339", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.115, "recommendationKey": "none", "totalCash": 3647026, "totalCashPerShare": 0.072, "totalDebt": 2147802, "quickRatio": 0.425, "currentRatio": 0.484, "returnOnAssets": -0.45279, "freeCashflow": 14462453, "operatingCashflow": -6629971, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]